$NVRO
NEVRO CORP

2020 Q3 Form 10-Q Financial Statement

#000156459020051431 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $108.5M $114.4M $100.2M
YoY Change 8.28% 5.96% 4.74%
Cost Of Revenue $32.40M $33.10M $30.22M
YoY Change 7.21% 4.09% 6.48%
Gross Profit $76.08M $81.26M $69.94M
YoY Change 8.77% 6.7% 4.0%
Gross Profit Margin 70.14% 71.05% 69.83%
Selling, General & Admin $68.50M $76.00M $72.91M
YoY Change -6.04% 6.59% 13.9%
% of Gross Profit 90.04% 93.53% 104.24%
Research & Development $11.10M $16.90M $13.02M
YoY Change -14.74% 25.19% 4.34%
% of Gross Profit 14.59% 20.8% 18.61%
Depreciation & Amortization $1.174M $1.250M $1.112M
YoY Change 5.58% 20.19% 3.15%
% of Gross Profit 1.54% 1.54% 1.59%
Operating Expenses $79.60M $93.00M $85.92M
YoY Change -7.36% 9.8% 12.34%
Operating Profit -$3.549M -$11.68M -$15.98M
YoY Change -77.8% 35.78% 73.04%
Interest Expense -$6.200M -$1.400M $2.755M
YoY Change -325.05% 16.67% -311.92%
% of Operating Profit
Other Income/Expense, Net $0.00 -$200.0K -$291.0K
YoY Change -100.0% -33.33% 191.0%
Pretax Income -$9.800M -$13.30M -$17.43M
YoY Change -43.77% 31.68% 62.87%
Income Tax $200.0K $500.0K $420.0K
% Of Pretax Income
Net Earnings -$9.985M -$13.74M -$17.85M
YoY Change -44.05% 43.04% 58.43%
Net Earnings / Revenue -9.21% -12.01% -17.82%
Basic Earnings Per Share
Diluted Earnings Per Share -$290.7K -$439.1K -$576.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $572.9M $237.8M $232.8M
YoY Change 146.13% -10.11% -9.78%
Cash & Equivalents $119.6M $65.37M $49.34M
Short-Term Investments $454.2M $172.4M $183.4M
Other Short-Term Assets $6.500M $9.800M $6.500M
YoY Change 0.0% 48.48% -9.72%
Inventory $84.15M $91.58M $90.73M
Prepaid Expenses
Receivables $78.70M $82.83M $70.81M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $742.3M $422.1M $400.8M
YoY Change 85.2% -4.91% -7.39%
LONG-TERM ASSETS
Property, Plant & Equipment $12.23M $11.77M $11.72M
YoY Change 4.38% -8.09% -11.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.900M $13.34M $11.91M
YoY Change -58.87% 128.0% 143.1%
Total Long-Term Assets $36.10M $47.59M $46.94M
YoY Change -23.09% 147.15% 156.49%
TOTAL ASSETS
Total Short-Term Assets $742.3M $422.1M $400.8M
Total Long-Term Assets $36.10M $47.59M $46.94M
Total Assets $778.4M $469.6M $447.7M
YoY Change 73.85% 1.41% -0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.50M $16.05M $19.77M
YoY Change 23.93% -31.73% -2.13%
Accrued Expenses $44.47M $50.97M $45.05M
YoY Change -1.28% 31.39% 43.92%
Deferred Revenue
YoY Change
Short-Term Debt $166.6M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $239.4M $70.61M $68.33M
YoY Change 250.37% 13.13% 27.0%
LONG-TERM LIABILITIES
Long-Term Debt $139.5M $160.3M $158.3M
YoY Change -11.86% 5.19% 5.16%
Other Long-Term Liabilities $19.70M $1.937M $1.712M
YoY Change 1050.7% -31.43% -28.67%
Total Long-Term Liabilities $159.2M $162.2M $160.0M
YoY Change -0.49% 4.52% 6.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $239.4M $70.61M $68.33M
Total Long-Term Liabilities $159.2M $162.2M $160.0M
Total Liabilities $398.7M $253.3M $249.6M
YoY Change 59.71% 16.39% 20.77%
SHAREHOLDERS EQUITY
Retained Earnings -$485.7M -$409.8M -$396.0M
YoY Change 22.65% 33.88%
Common Stock $626.4M $594.7M
YoY Change 13.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $379.8M $216.4M $198.1M
YoY Change
Total Liabilities & Shareholders Equity $778.4M $469.6M $447.7M
YoY Change 73.85% 1.41% -0.75%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$9.985M -$13.74M -$17.85M
YoY Change -44.05% 43.04% 58.43%
Depreciation, Depletion And Amortization $1.174M $1.250M $1.112M
YoY Change 5.58% 20.19% 3.15%
Cash From Operating Activities $11.33M -$13.48M -$3.370M
YoY Change -436.2% -369.6% -39.82%
INVESTING ACTIVITIES
Capital Expenditures -$1.400M -$1.430M -$660.0K
YoY Change 112.12% 320.59% -53.52%
Acquisitions
YoY Change
Other Investing Activities -$168.7M $9.070M -$11.87M
YoY Change 1321.57% -62.27% -8.69%
Cash From Investing Activities -$170.1M $7.650M -$12.54M
YoY Change 1256.7% -67.72% -13.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 760.0K 21.39M 3.000M
YoY Change -74.67% 1558.14% 614.29%
NET CHANGE
Cash From Operating Activities 11.33M -13.48M -3.370M
Cash From Investing Activities -170.1M 7.650M -12.54M
Cash From Financing Activities 760.0K 21.39M 3.000M
Net Change In Cash -158.0M 15.56M -12.91M
YoY Change 1124.17% -48.12% -34.17%
FREE CASH FLOW
Cash From Operating Activities $11.33M -$13.48M -$3.370M
Capital Expenditures -$1.400M -$1.430M -$660.0K
Free Cash Flow $12.73M -$12.05M -$2.710M
YoY Change -569.74% -325.66% -35.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
166608000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
70611000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3597000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20445000
nvro Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
nvro Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
216352000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252317000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
275881000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
88789000
us-gaap Operating Expenses
OperatingExpenses
233851000
us-gaap Gross Profit
GrossProfit
171874000
us-gaap Operating Expenses
OperatingExpenses
271890000
us-gaap Operating Income Loss
OperatingIncomeLoss
-61977000
us-gaap Operating Income Loss
OperatingIncomeLoss
-84798000
us-gaap Gross Profit
GrossProfit
187092000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2555000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4641000
us-gaap Interest Expense
InterestExpense
15311000
us-gaap Interest Expense
InterestExpense
8153000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-645000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13019000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33770000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42084000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
85924000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
160300000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75574000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-17847000
us-gaap Net Income Loss
NetIncomeLoss
-89944000
CY2019Q3 us-gaap Interest Expense
InterestExpense
2755000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.27
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
73000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33398454
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17427000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75378000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15984000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
558000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1603000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
362000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
440000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-516000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88826000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
420000
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
200000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
289000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
99000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.93
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30659117
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1118000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
539000
us-gaap Net Income Loss
NetIncomeLoss
-75936000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89405000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30222000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
80443000
CY2019Q3 us-gaap Gross Profit
GrossProfit
69940000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
245483000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72905000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
200081000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
229806000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-291000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-28021000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17364000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1187000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8483000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-24888000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1044000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
215080000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
147144000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
48340000
CY2020Q2 nvro Adjustments To Additional Paid In Capital Purchase Of Bond Hedges1
AdjustmentsToAdditionalPaidInCapitalPurchaseOfBondHedges1
-52390000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
34933000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8357000
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1551000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4690000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10087000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-41063000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
801000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
374428000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3202000
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2441000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13971000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9985000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
605000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
379780000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1928000
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
154000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10397000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-44076000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
521000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
214099000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2233000
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
406000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4095000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9724000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-182000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
201542000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3505000
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
497000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11194000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-17847000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
200000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
198097000
us-gaap Profit Loss
ProfitLoss
-75936000
us-gaap Profit Loss
ProfitLoss
-89944000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3654000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3306000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
2521000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
2423000
us-gaap Share Based Compensation
ShareBasedCompensation
32537000
us-gaap Share Based Compensation
ShareBasedCompensation
31315000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-130000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1794000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2395000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
106000
us-gaap Inventory Write Down
InventoryWriteDown
4216000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-493000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
190000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
264000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
128000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-459000
us-gaap Inventory Write Down
InventoryWriteDown
1832000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10510000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5889000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
122000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
48000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1459000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9191000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3237000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1194000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3315000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-107000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1858000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
558000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8716000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3866000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6516000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6267000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2654000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2170000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10668000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36750000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
437516000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
178478000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
155646000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
210703000
nvro Repayment From Investment In Private Company
RepaymentFromInvestmentInPrivateCompany
-7500000
nvro Repayment From Investment In Private Company
RepaymentFromInvestmentInPrivateCompany
5500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3387000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2041000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-277757000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24684000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
147144000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
189750000
nvro Payments Of Convertible Notes Debt Issuance Costs
PaymentsOfConvertibleNotesDebtIssuanceCosts
6105000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
34933000
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
52390000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5179000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1057000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
33613000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11761000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
341766000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10704000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-86000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-216000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53255000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1578000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66329000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51872000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
119584000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50294000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1032000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
429000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-103700000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50200000
us-gaap Net Income Loss
NetIncomeLoss
-75900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10700000
CY2020Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
147100000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-485700000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-409800000
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1868750
CY2019Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
490000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1409000
CY2020Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
628000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
690000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-406000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1086000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the condensed consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; clinical accruals; stock-based compensation; depreciation and amortization periods; inventory valuation; valuation of investments; and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by the management. Actual results may differ from those estimates under different assumptions or conditions.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States and is in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the periods ended September 30, 2020 and December 31, 2019.  The Company also held cash in foreign banks of approximately $6.0 million at September 30, 2020 and $12.1 million at December 31, 2019 that was not insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes and 2025 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses a combination of a direct sales force, sales agents and independent distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three and nine months ended September 30, 2020 and 2019, no single customer accounted for <span>10%</span> or more of the Company’s revenue. As of September 30, 2020 and December 31, 2019, no single customer accounted for 10% or more of the accounts receivable balance.</p>
CY2020Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6000000.0
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12100000
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
50700000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
52400000
CY2020Q3 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
900000
CY2019Q3 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
400000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
4200000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
900000
CY2020Q3 nvro Bad Debt Expense
BadDebtExpense
700000
nvro Bad Debt Expense
BadDebtExpense
2700000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
limited one- to five-year warranty
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2019Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
119000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2825000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M25D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M21D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1247000
CY2020Q3 nvro Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2399000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25187000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3739000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
21448000
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1236000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
172222000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
211000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1234000
us-gaap Operating Lease Cost
OperatingLeaseCost
3702000
us-gaap Operating Lease Cost
OperatingLeaseCost
3807000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19012000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21533000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3778000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3498000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17670000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20445000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
21448000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
23943000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1247000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1010000
us-gaap Operating Lease Payments
OperatingLeasePayments
3676000
us-gaap Operating Lease Payments
OperatingLeasePayments
2809000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
498234000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
286000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
498515000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
172429000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
498234000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
442329000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
442591000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
55905000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
55924000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50966000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
limited one- to five-year warranty
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
498515000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28694000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26354000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
55455000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
65225000
CY2020Q3 us-gaap Inventory Net
InventoryNet
84149000
CY2019Q4 us-gaap Inventory Net
InventoryNet
91579000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28866000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24772000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16632000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13006000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12234000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11766000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1174000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1112000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3654000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3306000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30111000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36056000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2275000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1633000
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1061000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2353000
CY2020Q3 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
914000
CY2019Q4 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
2157000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3534000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
243000
CY2020Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
991000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5587000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7346000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44473000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30929938
CY2020Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
933000
CY2019Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1291000
CY2019Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1178000
CY2020Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
686000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1426000
CY2019Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
565000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1596000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1446000
CY2020Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
991000
CY2019Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1216000
CY2020Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
991000
CY2019Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1216000
CY2020Q1 nvro Contingent Consideration Payment Secured By Convertible Notes
ContingentConsiderationPaymentSecuredByConvertibleNotes
8500000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9985000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-17847000
us-gaap Net Income Loss
NetIncomeLoss
-75936000
us-gaap Net Income Loss
NetIncomeLoss
-89944000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34356936
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33398454
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30659117
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.93
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9222447
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7090135
CY2020Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2500000
CY2019Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2900000

Files In Submission

Name View Source Status
0001564590-20-051431-index-headers.html Edgar Link pending
0001564590-20-051431-index.html Edgar Link pending
0001564590-20-051431.txt Edgar Link pending
0001564590-20-051431-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvro-10q_20200930.htm Edgar Link pending
nvro-10q_20200930_htm.xml Edgar Link completed
nvro-20200930.xsd Edgar Link pending
nvro-20200930_cal.xml Edgar Link unprocessable
nvro-20200930_def.xml Edgar Link unprocessable
nvro-20200930_lab.xml Edgar Link unprocessable
nvro-20200930_pre.xml Edgar Link unprocessable
nvro-ex311_10.htm Edgar Link pending
nvro-ex312_12.htm Edgar Link pending
nvro-ex321_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending